Ariosa says the sky is not falling, so Federal Circuit decision must stand
22-10-2015
Sequenom’s en banc bid boosted by support from US professors
02-09-2015
CAFC must end ‘existential threat’ to patents, argues Sequenom
19-08-2015
KonstantinChristian / Shutterstock.com
A US appeals court has affirmed that a patent covering the method of detecting foetal abnormalities in pregnant mothers is ineligible for protection because it applies to a “natural phenomenon”.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
Register here for free content, or subscribe for access to archive.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
The US Court of Appeals for the Federal Circuit; Sequenom; Ariosa; cffDNA; pre-natal test; Harmony Test; US District Court;
